Document is current
Any future updates will be listed below
-
Authors
Tadié, Jean-Marc
Locher, Clara
Maamar, Adel
Reignier, Jean
Asfar, Pierre
Commereuc, Morgane
Lesouhaitier, Mathieu
Gregoire, Murielle
Le Pabic, Estelle
Bendavid, Claude
Moreau, Caroline
Diehl, Jean-Luc
Gey, Alain
Tartour, Eric
Le Tulzo, Yves
Thibault, Ronan
Terzi, Nicolas
Gacouin, Arnaud
Roussel, Mikael
Delclaux, Christophe
Tarte, Karin
Cynober, Luc
-
Funding
Funding for this research was provided by:
Ministère des Affaires Sociales et de la Santé (API14/R/001)
Ministère des Affaires Sociales et de la Santé (API14/R/001)
- License Information
-
More Information
Article History
Received: 24 May 2023
Accepted: 18 September 2023
First Online: 3 October 2023
Declarations
:
: The research was conducted in accordance with the 1964 Helsinki Declaration. The study protocol was approved by the ethics committee from Brest, France (Comité de Protection des Personnes Ouest IV #2016–895) and by regulatory authorities (reference: 150806B-42). Signed informed consent was obtained from all the participants or their legally authorized representatives prior to enrollment and randomization.
: Jean-Marc Tadié received personal fees from Biomerieux; Nicolas Terzi received personal fees from Pfizer; Jean-Luc Diehl reports research supports, grants and personal fees from ALung Technologies, Xenios, Fresenius Medical Care and Baxter, RonanThibault reports Royalties for designing the Simple Evaluation of Food Intake® (SEFI®) (Knoë, le Kremlin Bicêtre, France), consulting fees from Nestlé Health Science, Servier, Baxter, BBraun, Fresenius-Kabi, Nutricia, LeCancer and Nutricia, NHC, Novonordisk; Luc Cynober is a shareholder of Citrage Co, member of the Citrage Co Scientific Committee.
